The Flow Cytometry Market is expected to reach $ 6.5
billion by 2020, growing at an average annual rate of 30.9% between 2020 and
2022, Clinical and diagnostic organizations must adopt innovative technologies
as the need to improve precision devices and produce faster results increases
and the need for smaller devices increases. Although it has gained popularity
in the life sciences industry, the cost of the instrument is hampering growth.
Because of this, many researchers are still reluctant to adopt this technology
in research technology. In addition, the advanced technology that brought
complex instrumentation requires highly skilled individuals to use these
instruments.
The flow cytometry market is in the development stage. The
increased precision of results and the presence of numerous flow cytometry
techniques, such as multicolor and multi-parameter flow cytometry, have
provided a strong foothold to support the growth of the majority of developed
countries and anticipate high potential in emerging economies. Asia Pacific and
Africa. These economies are demanding better health care technology at a
reasonable cost. Population growth, which requires an increase in chronic
diseases and an increase in patients requiring better diagnosis and treatment,
is a major factor influencing the flow cytometry market conditions, AMR
analysts Debbie Shields and Rohini Patil.
North America accounted for the largest share of revenue
i.e. 43.5% of the overall Global flow cytometry market at $1.2 billion in 2011.
The region is further expected to attain a market size of $2.8 billion by 2020
growing at a CAGR of 10.1%.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/90?utm_source=sy
The company profile in this includes:
·
Advanced analytical Technologies Inc.
·
Merck Millipore
·
Becton
·
Dickinson & co
·
Beckman Coulter
·
eBioscience
·
Partech
·
Life technologies corp.
·
Luminex Corp
·
Amnis Corp.
·
Morphosys AG.
The primary strategy employed by key players of the market
is products launch, which is due to demand for newer, faster, and higher
through put machines that deliver better results.
Immunotyping and signal transduction, for example,
have been playing a significant role in medical diagnostics. However,
conventional technologies used, have limited the accuracy and impacted the
result deliverance time of the diagnosis performed. Improving therapeutic
scenario is equally attracting focus on early diagnostic tools. Currently, many
cancer types have various treatment options; however, this depends on the time
of diagnosis and the stage of the cancer. Flow cytometry has been one of the
most prevalent technologies which offer solutions for most of the problems
discussed above. Key factors restraining the market include high instrument
costs and size, lack of awareness among probable users and need for trained
personnel. Most of the users are not aware of the advanced development in the
flow cytometry technology and believe that the instruments are space consuming,
complex in use and are of high cost, thus affecting the market growth.
Buy Now (Report & Data Pack Available with
Discounted Price): @ https://www.alliedmarketresearch.com/checkout/62071?utm_source=sy
The global market for flow cytometry is divided into
segments such as products, technology, end users, and applications. Instruments
market accounts for the largest share of revenue in the flow cytometry market
at present and is expected to remain as the highest revenue generator in 2020.
Increase in modularity, accessibility, incorporation of imaging capabilities,
availability of wavelengths and targets and size reduction are a few of the
significant trends in the market assisting in the adoption of the instruments
by the end users. On the other hand, reagents market is expected to experience
the highest growth rate of CAGR 12% during the analysis period. A Primary
reason escalating this segment is availability of several types of reagents
that find diverse usability depending on specific applications like
diagnostics, drug discovery, etc.
Two technologies are implemented in flow
cytometry based research and diagnosis, namely cell based and bead based
technologies. In the present scenario as well as throughout the analysis
period, cell based technique is leading the market in terms of revenue
generation. However, bead based technique is expected to beat this technology
in terms of adoption rate by 2020.
Access Full Summery @ https://www.alliedmarketresearch.com/flow-cytometry-market?utm_source=sy
No comments:
Post a Comment